Found: 138
Select item for more details and to access through your institution.
Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis.
- Published in:
- JNCI Cancer Spectrum, 2024, v. 8, n. 3, p. 1, doi. 10.1093/jncics/pkae021
- By:
- Publication type:
- Article
Analysis of Breast Cancer Mortality in the US—1975 to 2019.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 3, p. 233, doi. 10.1001/jama.2023.25881
- By:
- Publication type:
- Article
Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e237230, doi. 10.1001/jamanetworkopen.2023.7230
- By:
- Publication type:
- Article
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01129-x
- By:
- Publication type:
- Article
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials.
- Published in:
- Clinical Trials, 2022, v. 19, n. 5, p. 490, doi. 10.1177/17407745221112013
- By:
- Publication type:
- Article
Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Comparison of Bayesian vs Frequentist Adaptive Trial Design in the Stroke Hyperglycemia Insulin Network Effort Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 5, p. e2211616, doi. 10.1001/jamanetworkopen.2022.11616
- By:
- Publication type:
- Article
A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2022, v. 65, n. 3, p. 291, doi. 10.1002/mus.27472
- By:
- Publication type:
- Article
Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0255228
- By:
- Publication type:
- Article
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00813-8
- By:
- Publication type:
- Article
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00159-2
- By:
- Publication type:
- Article
90552 Evidence synthesis with reconstructed survival data.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0244418
- By:
- Publication type:
- Article
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 11, p. 3152, doi. 10.1002/ijc.33044
- By:
- Publication type:
- Article
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 8, p. 1, doi. 10.1371/journal.pone.0237693
- By:
- Publication type:
- Article
A nonparametric Bayesian basket trial design.
- Published in:
- Biometrical Journal, 2019, v. 61, n. 5, p. 1160, doi. 10.1002/bimj.201700162
- By:
- Publication type:
- Article
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Concern Regarding Age Distribution of Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- letter
Contributions of Screening and Treatment to Mortality From Breast Cancer-Reply.
- Published in:
- 2018
- By:
- Publication type:
- letter
Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models.
- Published in:
- Medical Decision Making, 2018, v. 38, p. 3S, doi. 10.1177/0272989X17737507
- By:
- Publication type:
- Article
A Bayesian Simulation Model for Breast Cancer Screening, Incidence, Treatment, and Mortality.
- Published in:
- Medical Decision Making, 2018, v. 38, p. 78S, doi. 10.1177/0272989X17714473
- By:
- Publication type:
- Article
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03631-z
- By:
- Publication type:
- Article
Distinguishing between CISNET model results versus CISNET models.
- Published in:
- 2018
- By:
- Publication type:
- letter
A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network.
- Published in:
- Clinical Trials, 2017, v. 14, n. 3, p. 246, doi. 10.1177/1740774516688900
- By:
- Publication type:
- Article
Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach.
- Published in:
- Scientific Reports, 2017, p. 42741, doi. 10.1038/srep42741
- By:
- Publication type:
- Article
The life cycles of six multi-center adaptive clinical trials focused on neurological emergencies developed for the Advancing Regulatory Science initiative of the National Institutes of Health and US Food and Drug Administration: Case studies from the Adaptive Designs Accelerating Promising Treatments Into Trials Project
- Published in:
- SAGE Open Medicine, 2017, v. 5, p. 1, doi. 10.1177/2050312117736228
- By:
- Publication type:
- Article
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 160, n. 2, p. 297, doi. 10.1007/s10549-016-4006-6
- By:
- Publication type:
- Article
Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
CNS Anticancer Drug Discovery and Development Conference White Paper.
- Published in:
- Neuro-Oncology, 2015, v. 17, p. vi1, doi. 10.1093/neuonc/nov169
- By:
- Publication type:
- Article
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 8, p. 1106, doi. 10.1093/neuonc/nou345
- By:
- Publication type:
- Article
Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis.
- Published in:
- BMC Medical Ethics, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12910-015-0022-z
- By:
- Publication type:
- Article
The Brave New World of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 5, p. 951, doi. 10.1016/j.molonc.2015.02.011
- By:
- Publication type:
- Article
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 107, doi. 10.1177/1740774515569011
- By:
- Publication type:
- Article
Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 1, doi. 10.1093/jnci/dju289
- By:
- Publication type:
- Article
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies: Application to an article in Cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 18, p. 2784, doi. 10.1002/cncr.28795
- By:
- Publication type:
- Article
Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 6, p. 1, doi. 10.1093/jnci/dju092
- By:
- Publication type:
- Article
Re: Concordance Between CYP2D6 Genotypes Obtained From Tumor-Derived and Germline DNA.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Response.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Predicting clinical trial results based on announcements of interim analyses.
- Published in:
- Trials, 2014, v. 15, n. 1, p. 1, doi. 10.1186/1745-6215-15-73
- By:
- Publication type:
- Article
Re: CYP2D6 Genotyping and the Use of Tamoxifen in Breast Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Response.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Predicting clinical trial results based on announcements of interim analyses.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials.
- Published in:
- Clinical Trials, 2013, v. 10, n. 5, p. 720, doi. 10.1177/1740774513497539
- By:
- Publication type:
- Article
The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0079114
- By:
- Publication type:
- Article